JP2023008912A5 - - Google Patents

Download PDF

Info

Publication number
JP2023008912A5
JP2023008912A5 JP2022104196A JP2022104196A JP2023008912A5 JP 2023008912 A5 JP2023008912 A5 JP 2023008912A5 JP 2022104196 A JP2022104196 A JP 2022104196A JP 2022104196 A JP2022104196 A JP 2022104196A JP 2023008912 A5 JP2023008912 A5 JP 2023008912A5
Authority
JP
Japan
Prior art keywords
drugs
alkyl
pharmaceutical composition
disorders
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022104196A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023008912A (ja
JP7655885B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2023008912A publication Critical patent/JP2023008912A/ja
Publication of JP2023008912A5 publication Critical patent/JP2023008912A5/ja
Application granted granted Critical
Publication of JP7655885B2 publication Critical patent/JP7655885B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022104196A 2021-06-30 2022-06-29 脂肪族酸アミド誘導体を含有する医薬組成物 Active JP7655885B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021108402 2021-06-30
JP2021108402 2021-06-30

Publications (3)

Publication Number Publication Date
JP2023008912A JP2023008912A (ja) 2023-01-19
JP2023008912A5 true JP2023008912A5 (cg-RX-API-DMAC7.html) 2023-12-12
JP7655885B2 JP7655885B2 (ja) 2025-04-02

Family

ID=85112098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022104196A Active JP7655885B2 (ja) 2021-06-30 2022-06-29 脂肪族酸アミド誘導体を含有する医薬組成物

Country Status (1)

Country Link
JP (1) JP7655885B2 (cg-RX-API-DMAC7.html)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
DE69618050T2 (de) * 1995-03-17 2002-07-11 Aventis Pharmaceuticals Inc., Cincinnati Substituierte Benzylthienylpiperazine, ihre Anwendung als Arzneimittel und Verfahren für ihre Herstellung
CA2505397A1 (en) 2002-11-08 2004-05-21 Warner-Lambert Company Llc Phenylalkyl and pyridylalkyl piperazine derivatives
ATE461925T1 (de) 2005-04-26 2010-04-15 Hypnion Inc Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung
CN102884059B (zh) 2010-03-11 2015-08-26 大日本住友制药株式会社 N-酰基环胺衍生物或其可药用盐
TWI917344B (zh) 2019-12-24 2026-03-11 日商住友製藥股份有限公司 脂肪族酸醯胺衍生物

Similar Documents

Publication Publication Date Title
JP2018058890A5 (cg-RX-API-DMAC7.html)
JP2021105032A5 (cg-RX-API-DMAC7.html)
JP2021519267A5 (cg-RX-API-DMAC7.html)
JP2018104454A5 (cg-RX-API-DMAC7.html)
RU2015143466A (ru) Нейроактивные стероиды и способы их применения
JP2017531020A5 (cg-RX-API-DMAC7.html)
CN109963854A (zh) 杂芳基并[4,3-c]嘧啶-5-胺类衍生物、其制备方法及其在医药上的应用
RU2008127501A (ru) Сульфонилзамещенные 1н-индолы в качастве лигандов 5-гидрокситриптаминовых рецепторов
RU2018130727A (ru) Органические соединения
RU2009103307A (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ
WO2005079802A8 (en) Bipyridyl amides as modulators of metabotropic glutamate receptor-5
JP2008534627A5 (cg-RX-API-DMAC7.html)
MX2023009294A (es) Analogos inspirados por oxa-ibogaina para el tratamiento de trastornos neurologicos y psiquiatricos.
JP2018505898A5 (cg-RX-API-DMAC7.html)
AR069260A1 (es) Compuesto 1-[2-(2, 4-dimetilfenilsulfanil)fenil]piperazina.usos terapeuticos de compuestos que tienen actividad combinada de sert (transportador de serotonina), 5-ht3 (receptor 3 de 5-hidroxitriptamina) y 5-ht1a (receptor 1a de 5-hidroxitriptamina).metodo de tratamiento.
RU2009136330A (ru) Тетрагидроизохинолиновые соединения в качестве модуляторов гистаминового н3 рецептора
JP2022515766A5 (cg-RX-API-DMAC7.html)
JP2003507367A5 (cg-RX-API-DMAC7.html)
JP2014526435A5 (cg-RX-API-DMAC7.html)
JP2015506382A5 (cg-RX-API-DMAC7.html)
JP2016155815A5 (cg-RX-API-DMAC7.html)
US20180092916A1 (en) Methods of treating disease-induced ataxia and non-ataxic imbalance
JP2024521747A5 (cg-RX-API-DMAC7.html)
RU2015112914A (ru) Бензимидазолы в качестве активных агентов для центральной нервной системы
JP2015521642A5 (cg-RX-API-DMAC7.html)